According to a new market report by Lucintel, the future of the electrophysiology market looks promising with opportunities in the hospitals, emergency clinics, cardiac centers, diagnostic centers, and healthcare providers. The electrophysiology market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are technological advancements, growing prevalence of atrial fibrillation, rapid growth in aging population with higher risk of target diseases, and increasing burden of cardiovascular diseases across the globe.
In this market, EP ablation catheters, diagnostic catheters, and EP laboratory devices are the major devices used in electrophysiology. On the basis of comprehensive research, EP ablation catheters will remain the largest segment and is also expected to witness highest growth during forecast period due to growing preference of catheter ablation for the treatment of cardiac arrhythmias and increased adoption by the physicians.
North America will remain the largest market over the forecast period due to rise in prevalence of cardiac arrhythmias and increase in geriatric population, and high adoption rate of technologically advanced electrophysiology devices.

Abbott Laboratories, Biosense Webster, Biotronik, Boston Scientific, GE Healthcare, Koninklijke Philips, Medtronic, Microport Scientific, St. Jude Medical, and Siemens are among the major manufacturers of electrophysiology market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the electrophysiology market by application, product type, indication, end user, and region. Lucintel has prepared a comprehensive research report entitled "Electrophysiology Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the electrophysiology market by application, product type, indication, end user, and region as follows:
By Application [$M shipment analysis for 2013 – 2024]:
• Electrophysiology Treatment Devices
• Electrophysiology Monitoring Devices
By Device Type [$M shipment analysis for 2013 – 2024]:
• EP Diagnostic Catheters
• EP Laboratory Devices
• EP Ablation Catheters
• Access Devices
By Indication [$M shipment analysis for 2013 – 2024]:
• Atrial Fibrillation
• Ventricular Fibrillation
• Atrioventricular Nodal Reentry Tachycardia
• Wolff-Parkinson-White (WPW)
• Right Atrial Tachycardia
• Right Atrial Flutter
• Left Atrial Flutter
• Right Ventricular Tachycardia
• Left Ventricular Tachycardia
By End-User [$M shipment analysis for 2013 – 2024]:
• Hospitals
• Emergency Clinics
• Cardiac Centers
• Diagnostic Centers
• Healthcare Providers
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• Rest of the World (ROW)
o Brazil

This research report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

This report answers following 11 key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the electrophysiology market by application (electrophysiology treatment devices and electrophysiology monitoring device), product (EP diagnostic catheters, EP laboratory devices, EP ablation catheters and access devices), indication (atrial fibrillation, ventricular fibrillation, atrioventricular nodal reentry tachycardia, wolff-parkinson-white (WPW), right atrial tachycardia, right atrial flutter, left atrial flutter, right ventricular tachycardia, left ventricular tachycardia), end user (hospitals, emergency clinics, cardiac centers, diagnostic centers, and healthcare providers), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW))?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the electrophysiology market?
Q.5. What are the business risks and threats to the electrophysiology market?
Q.6. What are emerging trends in this electrophysiology market and the reasons behind them?
Q.7. What are some changing demands of customers in the electrophysiology market?
Q.8. What are the new developments in the electrophysiology market? Which companies are leading these developments?
Q.9. Who are the major players in this electrophysiology market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this electrophysiology area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in this electrophysiology market?